Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients

British Journal of Haematology

Volumn 151, Issue 1, 2010, Pages 62-69

  Nur, Erfan ^a,b   Brandjes, Dees P ^a   Schnog, John John B ^a,c   Otten, Hans Martin ^a   Fijnvandraat, Karin ^b   Schalkwijk, Casper G ^d   Biemond, Bart J ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Sint Elisabeth Hospital   (Netherlands Antilles)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

advanced glycation end products; haemolysis; organ damage; oxidative stress; sickle cell disease

Indexed keywords

6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; PENTOSIDINE; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; ARGININE; BIOLOGICAL MARKER; LYSINE; N(6)-(1-CARBOXYETHYL)LYSINE; N(EPSILON)-(CARBOXYMETHYL)HYDROXYLYSINE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HEMOGLOBIN SC DISEASE; HEMOGLOBIN SD DISEASE; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SICKLE CELL CRISIS; STEADY STATE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ARGININE; BIOLOGICAL MARKERS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOLYSIS; HUMANS; LYSINE; MALE; MIDDLE AGED; OXIDATIVE STRESS; YOUNG ADULT;

EID: 77956824847     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08320.x     Document Type: Article

References (49)

1. Ahmed, N. (2005) Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Research and Clinical Practice, 67, 3 21.
2. Ahmed, M.U., Brinkmann, F.E., Degenhardt, T.P., Thorpe, S.R. Baynes, J.W. (1997) N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. The Biochemical Journal, 324 (Pt 2 565 570.
3. Akohoue, S.A., Shankar, S., Milne, G.L., Morrow, J., Chen, K.Y., Ajayi, W.U. Buchowski, M.S. (2007) Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatric Research, 61, 233 238.
4. Aronson, D. (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Journal of Hypertension, 21, 3 12.
5. van Beers, E.J., van Tuijn, C.F., Mac Gillavry, M.R., van der, G.A., Schnog, J.J. Biemond, B.J. (2008) Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice. Haematologica, 93, 757 760.
6. van Beijnum, J.R., Buurman, W.A. Griffioen, A.W. (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis, 11, 91 99.
7. Beisswenger, P.J., Makita, Z., Curphey, T.J., Moore, L.L., Jean, S., Brinck-Johnsen, T., Bucala, R. Vlassara, H. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes, 44, 824 829.
8. Botto, N., Masetti, S., Petrozzi, L., Vassalle, C., Manfredi, S., Biagini, A. Andreassi, M.G. (2002) Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coronary Artery Disease, 13, 269 274.
9. Brett, J., Schmidt, A.M., Yan, S.D., Zou, Y.S., Weidman, E., Pinsky, D., Nowygrod, R., Neeper, M., Przysiecki, C., Shaw, A., Migheli, A. Stern, D. (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. The American Journal of Pathology, 143, 1699 1712.
10. Brouwers, O., Niessen, P.M., Haenen, G., Miyata, T., Brownlee, M., Stehouwer, C.D., De Mey, J.G. Schalkwijk, C.G. (2010) Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia, 53, 989 1000.
11. Fibach, E. Rachmilewitz, E. (2008) The role of oxidative stress in hemolytic anemia. Current Molecular Medicine, 8, 609 619.
12. Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J.H. Suffredini, A.F. (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood, 101, 2652 2660.
13. Galaris, D. Pantopoulos, K. (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Critical Reviews in Clinical Laboratory Sciences, 45, 1 23.
14. Genuth, S., Sun, W., Cleary, P., Sell, D.R., Dahms, W., Malone, J., Sivitz, W. Monnier, V.M. (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes, 54, 3103 3111.
15. Gerrits, E.G., Lutgers, H.L., Kleefstra, N., Graaff, R., Groenier, K.H., Smit, A.J., Gans, R.O. Bilo, H.J. (2008) Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care, 31, 517 521.
16. Goldin, A., Beckman, J.A., Schmidt, A.M. Creager, M.A. (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation, 114, 597 605.
17. Greenwald, S.E. (2007) Ageing of the conduit arteries. The Journal of Pathology, 211, 157 172.
18. Hebbel, R.P., Morgan, W.T., Eaton, J.W. Hedlund, B.E. (1988) Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proceedings of the National Academy of Sciences of the United States of America, 85, 237 241.
19. Hirose, A., Tanikawa, T., Mori, H., Okada, Y. Tanaka, Y. (2010) Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Letters, 584, 61 66.
20. Jain, S.K. Shohet, S.B. (1984) A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease. Blood, 63, 362 367.
21. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G.M., Eaton, J.W. Balla, G. (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood, 100, 879 887.
22. Jones, I.R., Owens, D.R., Williams, S., Ryder, R.E., Birtwell, A.J., Jones, M.K., Gicheru, K. Hayes, T.M. (1983) Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care, 6, 501 503.
23. Kato, G.J., Martyr, S., Blackwelder, W.C., Nichols, J.S., Coles, W.A., Hunter, L.A., Brennan, M.L., Hazen, S.L. Gladwin, M.T. (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. British Journal of Haematology, 130, 943 953.
24. Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J., Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Morris, Jr., S.M. Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood, 107, 2279 2285.
25. Kato, G.J., Gladwin, M.T. Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews, 21, 37 47.
26. Klings, E.S. Farber, H.W. (2001) Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respiratory Research, 2, 280 285.
27. Klings, E.S., Christman, B.W., McClung, J., Stucchi, A.F., McMahon, L., Brauer, M. Farber, H.W. (2001) Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress. American Journal of Respiratory and Critical Care Medicine, 164, 1248 1252. (Pubitemid 33052259)
28. Koyama, Y., Takeishi, Y., Arimoto, T., Niizeki, T., Shishido, T., Takahashi, H., Nozaki, N., Hirono, O., Tsunoda, Y., Nitobe, J., Watanabe, T. Kubota, I. (2007) High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure. Journal of Cardiac Failure, 13, 199 206.
29. Landburg, P.P., Teerlink, T., Biemond, B.J., Brandjes, D.P., Muskiet, F.A., Duits, A.J. Schnog, J.B. (2010) Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. Blood Cells, Molecules & Diseases, 44, 229 232.
30. Lieuw A-Fa, M.L., van Hinsbergh, V.W., Teerlink, T., Barto, R., Twisk, J., Stehouwer, C.D. Schalkwijk, C.G. (2004) Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrology, Dialysis, Transplantation, 19, 631 636.
31. Lim, M., Park, L., Shin, G., Hong, H., Kang, I. Park, Y. (2008) Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Annals of the New York Academy of Sciences, 1150, 311 315.
32. Liu, J., Zhao, S., Tang, J., Li, Z., Zhong, T., Liu, Y., Chen, D., Zhao, M., Li, Y., Gong, X., Deng, P., Wang, J.H. Jiang, Y. (2009) Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. The FEBS Journal, 276, 4598 4606.
33. Miyata, T., Ishiguro, N., Yasuda, Y., Ito, T., Nangaku, M., Iwata, H. Kurokawa, K. (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochemical and Biophysical Research Communications, 244, 45 49.
34. Morris, C.R., Suh, J.H., Hagar, W., Larkin, S., Bland, D.A., Steinberg, M.H., Vichinsky, E.P., Shigenaga, M., Ames, B., Kuypers, F.A. Klings, E.S. (2008) Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood, 111, 402 410.
35. Nath, K.A., Grande, J.P., Croatt, A.J., Frank, E., Caplice, N.M., Hebbel, R.P. Katusic, Z.S. (2005) Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. The American Journal of Pathology, 166, 963 972.
36. Pertynska-Marczewska, M., Kiriakidis, S., Wait, R., Beech, J., Feldmann, M. Paleolog, E.M. (2004) Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine, 28, 35 47.
37. Powars, D.R., Hiti, A., Ramicone, E., Johnson, C. Chan, L. (2002) Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. American Journal of Hematology, 70, 206 215.
38. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O III., Schechter, A.N. Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383 1389.
39. Rice-Evans, C., Omorphos, S.C. Baysal, E. (1986) Sickle cell membranes and oxidative damage. The Biochemical Journal, 237, 265 269.
40. Scheijen, J.L., van de Waarenburg, M.P., Stehouwer, C.D. Schalkwijk, C.G. (2009) Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 877, 610 614.
41. Schnog, J.B., Rojer, R.A., Mac Gillavry, M.R., ten, C.H., Brandjes, D.P. Duits, A.J. (2003) Steady-state sVCAM-1 serum levels in adults with sickle cell disease. Annals of Hematology, 82, 109 113.
42. Sekido, H., Suzuki, T., Jomori, T., Takeuchi, M., Yabe-Nishimura, C. Yagihashi, S. (2004) Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells. Biochemical and Biophysical Research Communications, 320, 241 248.
43. Somjee, S.S., Warrier, R.P., Thomson, J.L., Ory-Ascani, J. Hempe, J.M. (2005) Advanced glycation end-products in sickle cell anaemia. British Journal of Haematology, 128, 112 118.
44. Soro-Paavonen, A., Zhang, W.Z., Venardos, K., Coughlan, M.T., Harris, E., Tong, D.C., Brasacchio, D., Paavonen, K., Chin-Dusting, J., Cooper, M.E., Kaye, D., Thomas, M.C. Forbes, J.M. (2010) Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. Journal of Hypertension, 28, 780 788.
45. Tatum, V.L. Chow, C.K. (1996) Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. Free Radical Research, 25, 133 139.
46. Teerlink, T., Barto, R., Ten Brink, H.J. Schalkwijk, C.G. (2004) Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clinical Chemistry, 50, 1222 1228.
47. Viberti, G.C. (1983) Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. The American Journal of Medicine, 75, 81 84.
48. Wetterstroem, N., Brewer, G.J., Warth, J.A., Mitchinson, A. Near, K. (1984) Relationship of glutathione levels and Heinz body formation to irreversibly sickled cells in sickle cell anemia. The Journal of Laboratory and Clinical Medicine, 103, 589 596.
49. Yamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M. Makita, Z. (2002) Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. The Journal of Biological Chemistry, 277, 20309 20315. (Pubitemid 34967325)